Who Paid My Doc
Elizabeth Munroe
Critical Care Medicine Murray, UT Medical Doctor
NPI 1104274059 CMS profile 1917137
5121 S Cottonwood St, --, Murray, UT 84107
General payments
$105
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Elizabeth Munroe of Murray, UT is reported in the CMS Open Payments database as having received $105 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 23rd percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $105 | 1 |
Beside peers
- Elizabeth Munroe
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Elizabeth Munroe were reported at $0. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Elizabeth Munroe | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $105 | $149 | $51–$535 | $163 |
| 2020 | $0 | $110 | $30–$325 | $114 |
| 2021 | $0 | $125 | $34–$403 | $132 |
| 2022 | $0 | $157 | $49–$582 | $149 |
| 2023 | $0 | $162 | $56–$621 | $160 |
| 2024 | $0 | $168 | $53–$634 | $164 |
| 2025 | $0 | $189 | $59–$844 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
273
Drug cost
$112,438
Branded share of claims
47.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Nucala Mepolizumab | Brand | 12 | $44,266 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 34 | $40,686 | |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | Brand | 17 | $12,846 | |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | Brand | 13 | $8,884 | |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | Brand | 23 | $3,700 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 30 | $1,045 | |
| Azithromycin | Generic | 44 | $461 | |
| Montelukast Sodium | Generic | 40 | $333 | |
| Prednisone | Generic | 38 | $85 | |
| Fluticasone Propionate | Generic | 11 | $81 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,233 Part D prescribers listed as Pulmonary Disease; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 32 billing codesPaid by Medicare
$23,427
Medicare patients
88
Services billed
320
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 74% | |
| COPD | 51% | |
| Arthritis | 49% | |
| Diabetes | 42% | |
| Chronic kidney disease | 42% | |
| Heart failure | 39% | |
| Ischemic heart disease | 34% | |
| Atrial fibrillation | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in Utah
Laura Frye
Critical Care Medicine · Salt Lake City, UT
David Fedor
Critical Care Medicine · Murray, UT
Peter Crossno
Critical Care Medicine · Murray, UT
Theodore Liou
Critical Care Medicine · Salt Lake City, UT
Nathan Brewster
Critical Care Medicine · American Fork, UT
James Rasmussen
Critical Care Medicine · Salt Lake City, UT
Related records
Critical Care Medicine in Utah
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Utah
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.